- Home
- MBWM vs LENZ Comparison
MBWM vs LENZ Comparison
Compare MBWM & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- LENZ
- Stock Information
- Founded
- MBWM 1997
- LENZ 2019
- Country
- MBWM United States
- LENZ United States
- Employees
- MBWM N/A
- LENZ N/A
- Industry
- MBWM Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- MBWM Finance
- LENZ Health Care
- Exchange
- MBWM Nasdaq
- LENZ Nasdaq
- Market Cap
- MBWM 704.2M
- LENZ 742.3M
- IPO Year
- MBWM 1997
- LENZ 2021
- Fundamental
- Price
- MBWM $43.84
- LENZ $25.87
- Analyst Decision
- MBWM Buy
- LENZ Strong Buy
- Analyst Count
- MBWM 2
- LENZ 5
- Target Price
- MBWM $52.25
- LENZ $41.80
- AVG Volume (30 Days)
- MBWM 50.1K
- LENZ 257.6K
- Earning Date
- MBWM 04-22-2025
- LENZ 05-07-2025
- Dividend Yield
- MBWM 3.36%
- LENZ N/A
- EPS Growth
- MBWM N/A
- LENZ N/A
- EPS
- MBWM 4.80
- LENZ N/A
- Revenue
- MBWM $222,296,000.00
- LENZ N/A
- Revenue This Year
- MBWM $8.87
- LENZ N/A
- Revenue Next Year
- MBWM $3.71
- LENZ $544.90
- P/E Ratio
- MBWM $9.02
- LENZ N/A
- Revenue Growth
- MBWM 0.96
- LENZ N/A
- 52 Week Low
- MBWM $35.61
- LENZ $14.42
- 52 Week High
- MBWM $52.98
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- MBWM 58.93
- LENZ 50.48
- Support Level
- MBWM $42.24
- LENZ $25.49
- Resistance Level
- MBWM $44.08
- LENZ $30.48
- Average True Range (ATR)
- MBWM 1.24
- LENZ 2.23
- MACD
- MBWM 0.40
- LENZ -0.09
- Stochastic Oscillator
- MBWM 91.47
- LENZ 42.09
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It provides a variety of commercial banking services to individuals, businesses, governmental units, and other institutions. It provides banking services offering deposit products including checking, savings, and term certificate accounts, and lending products including commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.